PNAA
TMO icon

Pictet North America Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Pictet North America Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.15M Buy
8,280
+157
+2% +$75.4K 0.37% 53
2026
Q1 		$3.99M Buy
8,123
+869
+12% +$472K 0.4% 56
2025
Q4 		$4.2M Sell
7,254
-246
-3% -$139K 0.4% 55
2025
Q3 		$3.64M Sell
7,500
-130
-2% -$60.5K 0.34% 59
2025
Q2 		$3.09M Sell
7,630
-1,359
-15% -$568K 0.31% 63
2025
Q1 		$4.47M Buy
8,989
+177
+2% +$95.9K 0.45% 56
2024
Q4 		$4.58M Buy
8,812
+69
+0.8% +$37.9K 0.44% 59
2024
Q3 		$5.41M Sell
8,743
-24
-0.3% -$14.2K 0.54% 47
2024
Q2 		$4.85M Sell
8,767
-5,946
-40% -$3.41M 0.53% 48
2024
Q1 		$8.55M Sell
14,713
-1,554
-10% -$872K 0.95% 26
2023
Q4 		$8.63M Sell
16,267
-323
-2% -$156K 1.12% 24
2023
Q3 		$8.4M Buy
16,590
+4,362
+36% +$2.32M 1.19% 19
2023
Q2 		$6.38M Buy
12,228
+76
+0.6% +$41K 0.88% 24
2023
Q1 		$7M Buy
12,152
+4,389
+57% +$2.47M 1.13% 22
2022
Q4 		$4.28M Sell
7,763
-248
-3% -$131K 0.74% 31
2022
Q3 		$4.06M Sell
8,011
-538
-6% -$301K 0.65% 34
2022
Q2 		$4.64M Sell
8,549
-328
-4% -$181K 0.62% 35
2022
Q1 		$5.24M Sell
8,877
-1,799
-17% -$1.03M 0.61% 34
2021
Q4 		$7.12M Buy
10,676
+318
+3% +$199K 0.7% 34
2021
Q3 		$5.92M Sell
10,358
-9
-0.1% -$4.94K 0.58% 37
2021
Q2 		$5.23M Buy
10,367
+7,622
+278% +$3.6M 0.54% 35
2021
Q1 		$1.25M Sell
2,745
-177
-6% -$84.5K 0.15% 65
2020
Q4 		$1.36M Sell
2,922
-803
-22% -$377K 0.17% 66
2020
Q3 		$1.65M Buy
3,725
+225
+6% +$93K 0.23% 58
2020
Q2 		$1.27M Hold
3,500
– – 0.18% 69
2020
Q1 		$993K Buy
3,500
+200
+6% +$63.1K 0.17% 76
2019
Q4 		$1.07M Buy
3,300
+330
+11% +$100K 0.13% 85
2019
Q3 		$865K Hold
2,970
– – 0.12% 91
2019
Q2 		$872K Buy
2,970
+215
+8% +$59.2K 0.13% 89
2019
Q1 		$754K Buy
2,755
+290
+12% +$72.2K 0.11% 96
2018
Q4 		$552K Buy
2,465
+64
+3% +$15K 0.05% 109
2018
Q3 		$586K Buy
2,401
+680
+40% +$156K 0.08% 114
2018
Q2 		$356K Hold
1,721
– – 0.05% 116
2018
Q1 		$355K Sell
1,721
-43
-2% -$9.03K 0.05% 109
2017
Q4 		$335K Hold
1,764
– – 0.05% 112
2017
Q3 		$334K Hold
1,764
– – 0.05% 105
2017
Q2 		$308K Buy
1,764
+48
+3% +$8.06K 0.05% 108
2017
Q1 		$264K Buy
+1,716
New +$262K 0.04% 116
2016
Q1 		– Sell
-1,985
Closed -$282K – 97
2015
Q4 		$282K Sell
1,985
-165
-8% -$22K 0.07% 74
2015
Q3 		$263K Buy
+2,150
New +$280K 0.07% 72
2015
Q2 		– Sell
-2,150
Closed -$289K – 83
2015
Q1 		$289K Buy
+2,150
New +$277K 0.05% 67

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Pictet North America Advisors's TMO Position: Q2 2026 in Review

Pictet North America Advisors increased its Thermo Fisher Scientific (TMO) stake by 1.9% in Q2 2026, buying an estimated $75.4K and bringing the position to 8,280 shares worth $4.15M. The position accounts for 0.37% of the portfolio, ranked #53.

Pictet North America Advisors first reported a position in TMO in Q1 2015 and has held it in 41 quarters since. The position peaked at $8.63M in Q4 2023. 1,030 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Pictet North America Advisors held 8,280 shares of Thermo Fisher Scientific worth $4.15M as of Q2 2026.
  • Pictet North America Advisors bought 157 Thermo Fisher Scientific shares in Q2 2026, an estimated $75.4K.
  • Thermo Fisher Scientific made up 0.37% of Pictet North America Advisors's portfolio in Q2 2026, its #53 holding.
  • Pictet North America Advisors first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 41 quarters since.
  • Pictet North America Advisors's Thermo Fisher Scientific position peaked at $8.63M in Q4 2023.
  • 1,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Pictet North America Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.